Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
group | 0.500 | strong | 0.963 | 0 | 0 | 1984 | 2020 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.130 | None | 1.000 | 0 | 0 | 1990 | 2000 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 1999 | 1999 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 |